Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by American International Group Inc.

American International Group Inc. reduced its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Rating) by 4.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 117,950 shares of the medical research company’s stock after selling 6,025 shares during the quarter. Thermo Fisher Scientific accounts for approximately 0.5% of American International Group Inc.’s holdings, making the stock its 27th largest holding. American International Group Inc.’s holdings in Thermo Fisher Scientific were worth $64,954,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. Morningstar Investment Services LLC purchased a new stake in shares of Thermo Fisher Scientific during the 4th quarter valued at about $225,000. Wade G W & Inc. increased its holdings in Thermo Fisher Scientific by 13.3% during the 4th quarter. Wade G W & Inc. now owns 3,999 shares of the medical research company’s stock worth $2,202,000 after purchasing an additional 470 shares during the last quarter. Amalgamated Bank increased its holdings in Thermo Fisher Scientific by 0.6% during the 4th quarter. Amalgamated Bank now owns 103,268 shares of the medical research company’s stock worth $56,869,000 after purchasing an additional 596 shares during the last quarter. Sei Investments Co. increased its holdings in Thermo Fisher Scientific by 18.9% during the 4th quarter. Sei Investments Co. now owns 253,680 shares of the medical research company’s stock worth $139,686,000 after purchasing an additional 40,315 shares during the last quarter. Finally, Bryn Mawr Capital Management LLC increased its holdings in Thermo Fisher Scientific by 200.1% during the 4th quarter. Bryn Mawr Capital Management LLC now owns 8,697 shares of the medical research company’s stock worth $4,789,000 after purchasing an additional 5,799 shares during the last quarter. 85.92% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Thermo Fisher Scientific

In related news, CEO Marc N. Casper sold 1,600 shares of the firm’s stock in a transaction dated Tuesday, May 9th. The stock was sold at an average price of $534.82, for a total transaction of $855,712.00. Following the completion of the transaction, the chief executive officer now owns 141,330 shares of the company’s stock, valued at $75,586,110.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, CEO Marc N. Casper sold 10,000 shares of the company’s stock in a transaction on Friday, May 5th. The stock was sold at an average price of $545.22, for a total transaction of $5,452,200.00. Following the completion of the sale, the chief executive officer now directly owns 141,330 shares of the company’s stock, valued at $77,055,942.60. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Marc N. Casper sold 1,600 shares of the company’s stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $534.82, for a total value of $855,712.00. Following the sale, the chief executive officer now directly owns 141,330 shares of the company’s stock, valued at $75,586,110.60. The disclosure for this sale can be found here. Insiders sold 19,100 shares of company stock valued at $10,391,587 over the last 90 days. 0.32% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have issued reports on TMO. SVB Leerink lifted their price objective on Thermo Fisher Scientific from $620.00 to $630.00 and gave the stock an “outperform” rating in a report on Thursday, February 2nd. KeyCorp lowered their price target on Thermo Fisher Scientific from $710.00 to $640.00 in a report on Thursday. Robert W. Baird lowered their price target on Thermo Fisher Scientific from $693.00 to $670.00 in a report on Thursday, April 27th. Morgan Stanley lowered their price target on Thermo Fisher Scientific from $670.00 to $620.00 in a report on Thursday, April 27th. Finally, StockNews.com began coverage on Thermo Fisher Scientific in a report on Thursday, May 18th. They issued a “hold” rating for the company. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $631.31.

Thermo Fisher Scientific Stock Performance

Shares of NYSE:TMO traded up $7.20 on Friday, hitting $527.84. The company’s stock had a trading volume of 736,909 shares, compared to its average volume of 1,420,386. Thermo Fisher Scientific Inc. has a 12 month low of $475.77 and a 12 month high of $611.06. The company has a market capitalization of $203.60 billion, a price-to-earnings ratio of 34.68, a price-to-earnings-growth ratio of 2.54 and a beta of 0.79. The stock’s 50-day moving average is $553.32 and its two-hundred day moving average is $554.74. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.92 and a current ratio of 1.27.

Thermo Fisher Scientific (NYSE:TMO – Get Rating) last released its quarterly earnings results on Wednesday, April 26th. The medical research company reported $5.03 earnings per share (EPS) for the quarter, hitting the consensus estimate of $5.03. Thermo Fisher Scientific had a return on equity of 19.16% and a net margin of 13.75%. The company had revenue of $10.71 billion during the quarter, compared to analysts’ expectations of $10.67 billion. During the same quarter in the prior year, the business posted $7.25 earnings per share. The company’s revenue for the quarter was down 9.4% compared to the same quarter last year. On average, equities research analysts forecast that Thermo Fisher Scientific Inc. will post 23.7 EPS for the current year.

Thermo Fisher Scientific Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 14th. Investors of record on Thursday, June 15th will be paid a dividend of $0.35 per share. The ex-dividend date is Wednesday, June 14th. This represents a $1.40 annualized dividend and a yield of 0.27%. Thermo Fisher Scientific’s dividend payout ratio is currently 9.13%.

Thermo Fisher Scientific Profile

(Get Rating)

Thermo Fisher Scientific, Inc engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.